We are the
Drug Safety Research Unit
A broard pharmacoepidemiology unit conducting studies to understand the effects of medicines in clinical use.
I’m interested in…
The Drug Safety Research Unit (DSRU) is an independent unit internationally respected for it’s work in Pharmacovigilance, Pharmacoepdiemiology, Risk Management, Risk Minimisation and Training Services for over 30 years.
The DSRU, led by Director Professor Saad Shakir, aims to protect patients from unwanted adverse effects of medicines in clinical use. The DSRU has grown into a board pharmacoepidemiological unit which uses a variety of methods to conduct a wide range of studies.
About
Lorem ipsum dolor sit amet consectetur
The Drug Safety Research Unit (DSRU) is an independent unit internationally respected for it’s work in Pharmacovigilance, Pharmacoepdiemiology, Risk Management, Risk Minimisation and Training Services for over 30 years.
Testimonials
What our clients have to say about us
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse metus sapien, tincidunt nec nunc sit amet, accumsan laoreet purus. Morbi ut dolor in lectus feugiat aliquam. Etiam sapien ex, blandit nec venenatis in, vestibulum vel risus. Aliquam eu turpis eu mauris finibus placerat eu ut odio. Etiam eget aliquam libero. Maecenas vitae interdum magna.
Cras egestas at lacus eget molestie. Suspendisse dictum semper ultricies. Suspendisse ac nisi vel massa malesuada dignissim. Etiam luctus purus ut tellus tincidunt lacinia. Phasellus laoreet fringilla feugiat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse metus sapien, tincidunt nec nunc sit amet, accumsan laoreet purus. Morbi ut dolor in lectus feugiat aliquam. Etiam sapien ex, blandit nec venenatis in, vestibulum vel risus. Aliquam eu turpis eu mauris finibus placerat eu ut odio. Etiam eget aliquam libero. Maecenas vitae interdum magna.
Cras egestas at lacus eget molestie. Suspendisse dictum semper ultricies. Suspendisse ac nisi vel massa malesuada dignissim. Etiam luctus purus ut tellus tincidunt lacinia. Phasellus laoreet fringilla feugiat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse metus sapien, tincidunt nec nunc sit amet, accumsan laoreet purus. Morbi ut dolor in lectus feugiat aliquam. Etiam sapien ex, blandit nec venenatis in, vestibulum vel risus. Aliquam eu turpis eu mauris finibus placerat eu ut odio. Etiam eget aliquam libero. Maecenas vitae interdum magna.
Cras egestas at lacus eget molestie. Suspendisse dictum semper ultricies. Suspendisse ac nisi vel massa malesuada dignissim. Etiam luctus purus ut tellus tincidunt lacinia. Phasellus laoreet fringilla feugiat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse metus sapien, tincidunt nec nunc sit amet, accumsan laoreet purus. Morbi ut dolor in lectus feugiat aliquam. Etiam sapien ex, blandit nec venenatis in, vestibulum vel risus. Aliquam eu turpis eu mauris finibus placerat eu ut odio. Etiam eget aliquam libero. Maecenas vitae interdum magna.
Cras egestas at lacus eget molestie. Suspendisse dictum semper ultricies. Suspendisse ac nisi vel massa malesuada dignissim. Etiam luctus purus ut tellus tincidunt lacinia. Phasellus laoreet fringilla feugiat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse metus sapien, tincidunt nec nunc sit amet, accumsan laoreet purus. Morbi ut dolor in lectus feugiat aliquam. Etiam sapien ex, blandit nec venenatis in, vestibulum vel risus. Aliquam eu turpis eu mauris finibus placerat eu ut odio. Etiam eget aliquam libero. Maecenas vitae interdum magna.
Cras egestas at lacus eget molestie. Suspendisse dictum semper ultricies. Suspendisse ac nisi vel massa malesuada dignissim. Etiam luctus purus ut tellus tincidunt lacinia. Phasellus laoreet fringilla feugiat.
News & events
Latest news, events & press releases from DSRU
DSRU attends DIA Europe conference
The DSRU team was delighted to attend the DIA Europe conference in Basel in March 2023 and to promote our capabilities as the UK’s leading pharmacovigilance and pharmacoepidemiology unit. The conference was an in-person only event, so it was great to meet face-to-face with friends and colleagues old and new. The broad scientific programme included […]
03/30/2023
How we’re leading UK pharmacovigilance
Here at the Drug Safety Research Unit, we are proud to be the UK’s leading pharmacovigilance and pharmacoepidemiology unit. We have conducted hundreds of post-authorisation observational studies using a wide range of methods over many years. We have been so busy that we have significantly expanded our research team in the last few months. So why […]
12/12/2022
International group redoubles efforts to improve detection of drug side effects
The International Working Group (IWG) on New Developments in Pharmacovigilance has resumed its work in earnest, following an extended break due to the pandemic. Members of the IWG marked the occasion by coming together for the first time since the pandemic caused a sharp reduction in its activities. The IWG brings together over 65 experts […]
11/08/2022
Just published: our paper on cases of thrombosis with concurrent thrombocytopenia following AstraZeneca Covid-19 vaccine.
In March 2021, rare signals of unusual clotting with concurrent low platelets began to emerge in people who had received at least one dose of the AstraZeneca Covid-19 vaccine. In order to gain a better understanding of this association, we conducted a review of the spontaneous reports received by the Yellow Card scheme in the […]
09/30/2022
Good to be back at ICPE!
The DSRU had a great conference at ICPE (International Conference on Pharmacoepidemiology & Therapeutic Risk Management) in Copenhagen last week. The in-person annual conference of the International Society for Pharmacoepidemiology (ISPE) returned after a 2 year break. We had a busy few days presenting our research, meeting delegates at our exhibition booth and reconnecting with […]
Our biennial Signal Detection conference is back!
After an extended break due to the pandemic, we are delighted that our iconic 11th Biennial Conference on Signal Detection and Signal Management in Pharmacovigilance will take place in London on 28-30th June. This conference is recognised by many as the most important event in the signal detection calendar. The aim of the conference is […]
09/29/2022
Risk minimisation at the DSRU
“The right medicine, at the right dose, at the right time, to the right patient” (GVP, Module XVI) Risk minimisation measures are actions taken to prevent or reduce the occurrence of adverse drug reactions, or to reduce the severity or impact on the patient of adverse reactions that do occur. Additional risk minimisation measures are […]
DSRU hosts ISoP Mid-Year Symposium
Beyond Spontaneous Reporting: integrating data from multiple sources to ensure medicines safety The Drug Safety Research Unit (DSRU) hosts an important international meeting for the International Society of Pharmacovigilance (ISoP). The meeting will explore many future horizons for pharmacovigilance. We are delighted to host this year’s Mid-Year Symposium of the International Society of Pharmacovigilance (ISoP), […]
Institute of Pharmacovigilance Sciences launched to improve global drug safety research methods
The Drug Safety Research Unit has today launched a new global Institute of Pharmacovigilance Sciences. A team of DSRU physicians, epidemiologists and biomedical scientists will study pressing medicine and vaccine safety issues, and contribute new or improved methods for conducting drug safety research, as part of their work for the Institute. External researchers will also […]
DSRU launches Institute of Pharmacovigilance Sciences with free webinar
The DSRU Institute of Pharmacovigilance Sciences has been established to build on the DSRU’s methodological research in pharmacovigilance and pharmacoepidemiology. The launch of the Institute marks a major expansion in the DSRU’s expertise and track record in methodological and pharmacovigilance research, both to improve existing methods and propose new ones. The institute will study important […]